"We can now identify a cancer’s mutations and respond with appropriate therapy without the issues inherent in solid tissue biopsy – not only the delays, but also the intratumoral heterogeneity that is often missed when sampling only one or a few tumor sites." - Dr. Paul Walker Read the full story.
Topics: ddPCR, liquid biopsy, lung cancer, droplet digital PCR, liquid biopsy vs tissue biopsy, In the News